Abbott Receives European Regulatory Approval for New Ovarian Cancer Diagnostic Test
Abbott announces CE Mark (Conformite Europeene) certification for the ARCHITECT human epididymis protein 4 (HE4) test
19-Jan-2010 -
A new diagnostic tool, which studies show can aid in determining the risk of whether a pelvic mass is benign or malignant, is now available in Europe. This simple blood test is expected to help in the assessment of epithelial ovarian cancer. This immunoassay is the first automated HE4 test ...
Abbott
blood tests
diagnostics
+2